SenzaGen AB

About:

Senzagen offers animal-free testing of chemical compounds using genomics-based methodology for immunotoxicological assays.

Website: http://www.senzagen.com/

Twitter/X: senzagenab

Top Investors: EASME - EU Executive Agency for SMEs

Description:

Senzagen is a spin out company from Lund University with expertise in immunology, technology and genomics. SenzaGen markets, sells and performs the in vitro GARD sensitization test through its own laboratory and through licenced CROs. It offers animal-free testing of chemical compounds using genomics-based methodology for immunotoxicological assays. Their proprietary lead product family, GARD, potentially replaces the need for animal testing in the cosmetic, chemical and pharmaceutical industries.